Targeting the COX1/2-Driven thromboxane A2 pathway suppresses Barrett's esophagus and esophageal adenocarcinoma development

Tianshun Zhang(Hong Kong Polytechnic University), Zigang Dong(China-US (Henan) Hormel Cancer Institute)
EBioMedicine
November 1, 2019
Cited by 10


Related Papers